CBNS Director receives Australian Friends of Tel Aviv University – Monash University (AFTAM) Award
New paper out on the capacity of new-generation broadly neutralizing antibodies (BnAbs)
CBNS CIs and PIs are on Highly Cited Researchers 2018 list
Physical and toxicological profiles of human IAPP amyloids and plaques
Is There a Link between Structure and Cytotoxicity? New paper out on self‐assembled nanostructured lipid systems
Great success at the 1st Controlled Release Asia Conference and the Globalisation of Pharmaceutical Network Meeting in Singapore
Our Research
The research focus of the CBNS is to understand the bio-nano interface to better predict, control and visualise the myriad interactions that occur between nanomaterials and the biological environment.
People
464
View Profiles
Publications
946
Explore
Projects
35
Discover
Collaborations
39+
Collaborate
CBNS
@ARCCoEBionano
5 days ago
Please join us in congratulating CBNS Director Prof Tom Davis who has received an Australian Friends of Tel Aviv University – Monash University (AFTAM) award! More:
https://t.co/w4wLoGN6Gl
@MIPS_Australia
@MonashPharm
https://t.co/U9QY5KcvMQ
View on Twitter
2
Search our site & publications
Latest News
Grants and Awards
CBNS Director receives Australian Friends of Tel Aviv University – Monash University (AFTAM) Award
December 11, 2018
Publications
New paper out on the capacity of new-generation broadly neutralizing antibodies (BnAbs)
December 6, 2018
Announcement
CBNS CIs and PIs are on Highly Cited Researchers 2018 list
December 5, 2018
Upcoming Events
